Electrochemical glycoproteins sensor for sensitive diagnosis of PD: Ag@MSNs-MPBA as a specific signal amplifier and reporter.

Glycoprotein non-metastatic melanoma protein B (GPNMB) is a candidate biomarker of Parkinson's disease (PD). The development of a novel method for highly sensitive and specific detection of GPNMB is essential for PD's early and accurate diagnosis. An electrochemical biosensor was developed utilizing silver nanoparticle-loaded mesoporous silica (Ag@MSNs) with 4-mercaptophenylboronic acid (4-MPBA) modification for the sensitive and selective detection of GPNMB. MSNs were utilized as an excellent loading substrate for silver nanoparticles. 4-MPBA at the surface of Ag@MSNs can bind GPNMB specifically through the boronic acid group and multi-glycosylation sites of GPNMB. The finally prepared Ag@MSNs-MPBA exhibited a core-shell structure, which served as a highly efficient electrochemical signal amplifier and selective binding reporter. The enhanced electrochemical signal sensitivity was attributed to the output of the electrochemical signal of Ag through preventing the agglomeration of AgNPs and efficient capture of GPNMB by Ag@MSNs-MPBA. The analysis results demonstrated that the developed electrochemical sensor successfully detected GPNMB with an LOD as low as 0.9011 ng/mL (S/N = 3) in the detection range 1 to 100 ng/mL. The low-cost Ag@MSNs-MPBA replaces the conventional secondary antibody and can integrate signal labels and signal amplification. This work highlights the significant improvement in electrochemical sensing and detection performance achieved by utilizing Ag@MSNs-MPBA, providing a straightforward and general approach for low-cost and sensitive detection of glycoproteins through electrochemical measurement.